IL17A and systemic lupus erythematosus: As illustrated in Fig. 8, our findings clearly indicated that NCTD significantly alleviates the lupus symptoms of MRL/lpr mice by blocking IL-17-producing cell accumulation including DN T cells and Th17 cells.